Tracheobronchial Secretion Removal

Not Applicable

Completed

• Conditions: Respiration, Artificial; Respiratory Insufficiency
• Interventions: Device: TBA care device; Device: Control

• Registration Number: NCT00932776
• Lead Sponsor: University of Milano Bicocca

Brief Summary

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.

Detailed Description

Not available

Study Timeline

• Status Verified: 2009-07
• Study First Submitted: 2009-07-02
• Study First Submitted QC: 2009-07-02
• Last Update Submitted: 2009-07-02
• Study First Posted: 2009-07-03
• Last Update Posted: 2009-07-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• age greater than 18 years
• presence of an endotracheal tube to provide mechanical ventilation
• expected duration of mechanical ventilation greater than 48 hours.

Exclusion Criteria

• age < 18 years, pregnancy
• presence of active bronchial bleeding

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
TBA	TBA care device	-
Control	Control	-

Trial Locations

Locations (1)

A.O. San Gerardo; 🇮🇹 Monza, MB, Italy